tirzepatide administration FDA Grants a New Indication for Obesity Management Tirzepatide Pens: Do's and Don't

Patients with consistent morning routines may find it easier to remember daily injections before breakfast, while those with variable morning schedules might prefer evening dosing

Surprising Fact An Interpol officer told Reuters many fake obesity drugs are being sold in wealthy countries, a stark contrast to the poorer regions where most fake drugs are usually marketed

No downtime or side effects

Thymosin Alpha-1 (TA1) Thymosin Alpha-1 is an immune-modulating peptide originally discovered in the thymus gland

Cagrilintide is an amylin receptor agonist that some providers combine with tirzepatide for enhanced appetite suppression

Plus, more from The Bump: Uma Darji, MD, IBCLC, is a family physician and lactation consultant in Raleigh, North Carolina